comprehensive -WSS

comprehensive

author：explore 2025-09-06 06:00:01 - browse：55261

The Food and Drug Administration on Friday approved the world’s first medicine based on CRISPR gene-editing technology, a groundbreaking treatment for sickle cell disease that delivers a potential cure for people born with the chronic and life-shortening blood disorder.

The new medicine, called Casgevy, is made by Vertex Pharmaceuticals and CRISPR Therapeutics. Its authorization is a scientific triumph for the technology that can efficiently and precisely repair DNA mutations — ushering in a new era of genetic medicines for inherited diseases.

In a clinical trial, Casgevy was shown to eliminate recurrent episodes of debilitating pain caused by sickle cell, which afflicts approximately 100,000 people in the U.S., a vast majority of whom are Black. The therapy, whose scientific name is exa-cel, is described as a potential cure because the genetic fix enabled by CRISPR is designed to last a lifetime, although confirmation will require years of follow-up.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Can food be medicine? And other questions about a new push

hotspot

WSS

Why Titanic fascinates society, still drawing tours to the wreckage

Kansas must stop changing trans people's sex listing on driver's licenses, judge says

Doctor appointment wait times are getting worse

Rare Northern Lights show in US this week: Where and how to see it

How corporate America is slashing DEI workers amid backlash to diversity programs

RaDonda Vaught case: a double standard for nurses, physicians

focus

comprehensive

entertainment

Sports medicine is finally prioritizing gender equality

With fresh data, a dynamic duo powers Eli Lilly to new heights

Jerome Adams on the need for new antivirals for Covid

Kansas must stop changing trans people's sex listing on driver's licenses, judge says

New air purifier tech could be key to improving indoor air quality

Ukraine, Russia accuse each other of planning to attack Europe's biggest nuclear plant

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Van's Gluten Free Original Waffles recalled for possible wheat allergen

In Memoriam: Notable people who died in 2023

FDA approves Leqembi, a milestone in Alzheimer’s treatment

focus

Doctor appointment wait times are getting worse

US intelligence assessment says Iran not currently developing nuclear weapons

Russia says it foiled Ukrainian drone attack on Moscow as Kyiv's counteroffensive grinds on

US intelligence assessment says Iran not currently developing nuclear weapons

Ukraine, Russia accuse each other of planning to attack Europe's biggest nuclear plant

FDA approves Leqembi, a milestone in Alzheimer’s treatment

explore

hotspot

Wikipedia

focus